Clinical Trial Update: Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of hydroxychloroquine for sudden sensorineural hearing loss; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Sudden Hearing Loss | Phase 2 | Status: NOT_YET_RECRUITING